Source study found
Story checked
Brain Scans of 24 People With Long COVID Reveal Signs of Injury to Dopamine Neurons : ScienceAlert (opens in a new tab)
sciencealert.com · 2026-10-04
Short answer
Needs reviewStudy found.
We found the study, but the claim check did not finish.
Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.
Share this check
The story
Brain Scans of 24 People With Long COVID Reveal Signs of Injury to Dopamine Neurons : ScienceAlert
sciencealert.com · 2026-10-04
The story’s checkable claims.
Read the original story (opens in a new tab)NewsLink checks it
We found the study behind this story.
We found the study, but couldn't compare the story to it: the study's evidence could not be profiled.
Open claim evidenceThe source study
Loss of vesicular monoamine transporter 2 in striatum of long COVID and relationship to neuropsychiatric symptoms
Source layer
The 2 papers the story cites
Source study separated from background citations.
The research anchor for the report.
- The study this story reportspresented as the new finding
Loss of vesicular monoamine transporter 2 in striatum of long COVID and relationship to neuropsychiatric symptoms
eBioMedicine · 2026
- Cited as backgroundpresented as earlier work
SARS-CoV-2 infection causes dopaminergic neuron senescence
Cell Stem Cell · 2024
Evidence layer
Claim by claim
The source study was found, but the study's evidence could not be profiled, so these claims couldn't be checked.
Reading mode
Scan verdicts. Open evidence only when needed.
Claim 1 of 5Not checkedA preliminary study in Canada of 24 people with long COVID found distinct changes in some brain regions compared with healthy participants of the same age.View evidenceHide evidence
As stated24 people with long COVID
Not checked
The source study was found, but this claim couldn't be checked against it.
Claim 2 of 5Not checkedThe study found a reduction in the density of dopamine nerve endings in several regions of the striatum in the long COVID group compared with healthy controls.View evidenceHide evidence
Not checked
The source study was found, but this claim couldn't be checked against it.
Claim 3 of 5Not checkedThe severity of some long COVID symptoms was correlated with dopamine-neuron marker loss, and the article says roughly 25 percent of symptom variance was associated with a loss of dopaminergic neurons.View evidenceHide evidence
As statedroughly 25 percent of the variance
Not checked
The source study was found, but this claim couldn't be checked against it.
Claim 4 of 5Not checkedThe authors argue the findings suggest long COVID may be, at least in part, a disorder of the brain's dopamine system and that dopamine-targeting interventions could have therapeutic value, but the article notes this is preliminary and not yet tested in current trials.View evidenceHide evidence
Not checked
The source study was found, but this claim couldn't be checked against it.
Claim 5 of 5Not checkedThe article notes the research was published in eBioMedicine and that the authors also point to a prior small autopsy study as context for the hypothesis.View evidenceHide evidence
Not checked
The source study was found, but this claim couldn't be checked against it.
Method layer
NewsLink found the paper. Tessa takes you deeper.
NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.
Open the paper in Tessa
Loss of vesicular monoamine transporter 2 in striatum of long COVID and relationship to neuropsychiatric symptoms
eBioMedicine · 2026
Why this one
Near certain
NewsLink found the paper. Tessa is where you inspect it deeply.
Papers considered
The selected paper, plus nearby candidates.
Crossref, PubMed, Europe PMC · 17 candidate papers
Loss of vesicular monoamine transporter 2 in striatum of long COVID and relationship to neuropsychiatric symptoms
eBioMedicine · 2026 · Crossref
SARS-CoV-2 infection causes dopaminergic neuron senescence
Cell Stem Cell · 2024 · Crossref
A Neuroimmunological Axis between systemic autoimmunity and Parkinson's disease following long-COVID: A case series.
Journal of Neuroimmunology · 2026 · PubMed
Faculty Opinions recommendation of PET study examining pharmacokinetics, detection and likeability, and dopamine transporter receptor occupancy of short- and long-acting oral methylphenidate.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · 2006 · Crossref
Immunomodulatory Mechanisms Underlying Neurological Manifestations in Long COVID: Implications for Immune-Mediated Neurodegeneration.
2025 · Europe PMC
Electroencephalographic Abnormalities in a Patient Suffering from Long-Term Neuropsychological Complications following SARS-CoV-2 Infection.
Case Reports in Neurology · 2024 · PubMed
And 11 more candidates considered.